Patient-specific Models of Cancer (PMC) Seminar series

Diese Webseite benötigt JavaScript, um richtig zu funktionieren.

22 März 2022

Zeit: 12:30 - 13:30

Ort: Zoom

Veranstalter:
Clémentine Le Magnen on behalf of the PMC Steering Committee

Maren Diepenbruck/Tiberius Preca, Tumor Heterogeneity Metastasis and Resistance Group and Sandro Nuciforo/Lauriane Blukacz, Hepatology Group

A drug screening platform for breast cancer organoids

and

Patient-derived organoid models for drug discovery in hepatocellular carcinoma

Social Media